XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Total
Accumulated other comprehensive loss
Common Stock
Additional Paid in Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2023     13,798,669    
Balance, amount at Dec. 31, 2023 $ 16,982,186 $ 0 $ 137,983 $ 184,291,414 $ (167,447,211)
Net loss (2,111,658)       (2,111,658)
Stock-based compensation 396,312     396,312  
Stock issued for vested restricted stock awards, shares     144,487    
Stock issued for vested restricted stock awards, amount 0   $ 1,445 (1,445)  
Shares withheld for taxes on vested restricted stock (161,973)     (161,973)  
Balance, shares at Mar. 31, 2024     13,943,156    
Balance, amount at Mar. 31, 2024 15,104,867 0 $ 139,428 184,524,308 (169,558,869)
Balance, shares at Dec. 31, 2023     13,798,669    
Balance, amount at Dec. 31, 2023 16,982,186 0 $ 137,983 184,291,414 (167,447,211)
Net loss (3,858,849)        
Balance, shares at Jun. 30, 2024     14,043,711    
Balance, amount at Jun. 30, 2024 13,539,570 0 $ 140,434 184,705,196 (171,306,060)
Balance, shares at Mar. 31, 2024     13,943,156    
Balance, amount at Mar. 31, 2024 15,104,867 0 $ 139,428 184,524,308 (169,558,869)
Net loss (1,747,191)       (1,747,191)
Stock-based compensation 318,681     318,681  
Stock issued for vested restricted stock awards, shares     100,555    
Stock issued for vested restricted stock awards, amount 0   $ 1,006 (1,006)  
Stock warrants issued for referral agreement (136,787)     (136,787)  
Balance, shares at Jun. 30, 2024     14,043,711    
Balance, amount at Jun. 30, 2024 13,539,570 $ 0 $ 140,434 184,705,196 (171,306,060)
Balance, shares at Dec. 31, 2024     14,050,483    
Balance, amount at Dec. 31, 2024 13,474,772   $ 140,501 186,543,283 (173,209,012)
Net loss (1,259,821)       (1,259,821)
Stock-based compensation 304,284     304,284  
Stock issued for vested restricted stock awards, shares     151,893    
Stock issued for vested restricted stock awards, amount 0   $ 1,519 (1,519)  
Shares withheld for taxes on vested restricted stock (201,359)     (201,359)  
At-the-market sale of common stock, net of issuance costs, shares     159,432    
At-the-market sale of common stock, net of issuance costs, amount 1,128,838   $ 1,594 1,127,244  
Balance, shares at Mar. 31, 2025     14,361,808    
Balance, amount at Mar. 31, 2025 13,446,714   $ 143,614 187,771,933 (174,468,833)
Balance, shares at Dec. 31, 2024     14,050,483    
Balance, amount at Dec. 31, 2024 13,474,772   $ 140,501 186,543,283 (173,209,012)
Net loss (2,761,084)        
Balance, shares at Jun. 30, 2025     14,473,843    
Balance, amount at Jun. 30, 2025 12,079,639   $ 144,734 187,904,996 (175,970,096)
Balance, shares at Mar. 31, 2025     14,361,808    
Balance, amount at Mar. 31, 2025 13,446,714   $ 143,614 187,771,933 (174,468,833)
Net loss (1,501,263)       (1,501,263)
Stock-based compensation 291,789     291,789  
Stock issued for vested restricted stock awards, shares     112,035    
Stock issued for vested restricted stock awards, amount 0   $ 1,120 (1,120)  
Shares withheld for taxes on vested restricted stock (157,606)     (157,606)  
Balance, shares at Jun. 30, 2025     14,473,843    
Balance, amount at Jun. 30, 2025 $ 12,079,639   $ 144,734 $ 187,904,996 $ (175,970,096)